Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection

Approval Number

国药准字S20030006

Company辽宁卫星生物制品研究所（有限公司）

Registration Date

June 24, 2020

Drug Information

Generic Name

注射用重组人粒细胞巨噬细胞刺激因子

Brand Name

迪利升

Dosage Form

注射剂

Strength

150万IU/150μg/1ml/支

Drug Type

生物制品

Registration Date

June 24, 2020

Company Information

Applicant Company

Company Name辽宁卫星生物制品研究所（有限公司）

Manufacturing Company

Company Name辽宁卫星生物制品研究所（有限公司）

Company Address

沈阳市大东区东站街51甲-3号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用重组人粒细胞巨噬细胞刺激因子 - NMPA 批准文号 | MedPath